Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.60% | 2.79% | 7.31% | 6.75% | 4.37% |
| Total Depreciation and Amortization | -70.69% | -64.28% | -55.23% | -58.35% | -5.57% |
| Total Amortization of Deferred Charges | -52.28% | 4,648.15% | 5,252.08% | 5,613.33% | 3,754.35% |
| Total Other Non-Cash Items | -6.64% | -8.42% | -3.71% | -0.10% | 13.24% |
| Change in Net Operating Assets | 131.47% | 59.57% | 33.42% | 1.29% | -19.69% |
| Cash from Operations | 10.21% | 10.33% | 16.15% | 14.66% | 15.57% |
| Capital Expenditure | 45.60% | -8.35% | -79.31% | -96.17% | -182.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,342.97% | 1,066.15% | 1,676.92% | 172.39% | -893.75% |
| Cash from Investing | 933.70% | 813.36% | 970.75% | 3,014.29% | -454.23% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -4.30% | -1.06% | -1.06% | -3.33% | -3.33% |
| Issuance of Common Stock | -17.14% | -23.20% | -2.41% | -12.90% | -22.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.82% | -24.68% | -93.63% | -93.86% | -93.44% |
| Foreign Exchange rate Adjustments | -10,133.33% | -226.23% | 123.53% | -843.18% | -117.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.32% | 110.98% | 30.58% | -81.13% | -90.38% |